Skip to content

Early Detection & Intervention of Cerebral Palsy in Ireland

Early Detection & Intervention of Cerebral Palsy in Ireland

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05907837
Enrollment
1500
Registered
2023-06-18
Start date
2023-07-01
Completion date
2028-06-30
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Neurodevelopmental Disorders

Brief summary

Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity. This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.

Interventions

None listed

Sponsors

National Maternity Hospital, Ireland
CollaboratorOTHER
University Maternity Hospital Limerick
CollaboratorUNKNOWN
Cork University Maternity Hospital
CollaboratorOTHER
Coombe Women and Infants University Hospital
CollaboratorOTHER
The Rotunda Hospital
CollaboratorOTHER
Cerebral Palsy Foundation
CollaboratorUNKNOWN
University College Cork
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol. * All infants considered high risk for cerebral palsy and neuro-developmental impairment will be eligible, specifically including: * All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight * All encephalopathic infants * Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam)

Exclusion criteria

* Death prior to discharge from the neonatal unit.

Design outcomes

Primary

MeasureTime frameDescription
Reduce the age of CP diagnosis in Ireland.5 yearsReduce the age of diagnosis of cerebral palsy in Ireland to less than 12 months of age by using evidence based standardised motor and neurological assessments at set time points.
Standardised Approach to Assessing infant at risk of CP5 yearsTo establish a standardised approach to assessing infants at risk of CP in High Risk Follow-up Clinics across Ireland.

Countries

Ireland

Contacts

Primary ContactBrian H Walsh
brianhenry.walsh@ucc.ie021 42020529
Backup ContactTeresa Berkery
t.berkery@ucc.ie

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026